Large-scale testing (Phase 3)Study completedNCT05614063What this trial is testingStudy of XEN1101 Versus Placebo in Focal-Onset SeizuresWho this might be right forFocal Onset Seizures Xenon Pharmaceuticals Inc. 380
Large-scale testing (Phase 3)WithdrawnNCT03108729What this trial is testingA Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the DrugWho this might be right forEpilepsy Sumitomo Pharma America, Inc.
Not applicableNot Yet RecruitingNCT07343609What this trial is testingPredictive Value of Seizure Frequency at Onset for Long-Term Seizure ControlWho this might be right forNewly Diagnosed Epilepsy With Focus on Seizure Frequency at Onset and Long-term Seizure Control Assiut University 100
Post-approval studies (Phase 4)Study completedNCT05533814What this trial is testingEvaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic SeizuresWho this might be right forEpilepsy Eisai Korea Inc. 125
Post-approval studies (Phase 4)Not Yet RecruitingNCT06534502What this trial is testingStudy of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset SeizuresWho this might be right forSeizuresSeizures, FocalSeizure, Partial Onset+4 more Azurity Pharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT03373383What this trial is testingStudy to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant EpilepsyWho this might be right forDrug-resistant EpilepsyFocal-Onset Seizures UCB Biopharma S.P.R.L. 411
Testing effectiveness (Phase 2)Looking for participantsNCT06798896What this trial is testingRENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults with Focal Onset SeizuresWho this might be right forFocal Onset Seizures Supernus Pharmaceuticals, Inc. 258
Testing effectiveness (Phase 2)Study completedNCT04836559What this trial is testingInvestigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in EpilepsyWho this might be right forFocal Onset Seizures Janssen Research & Development, LLC 110
Post-approval studies (Phase 4)Active Not RecruitingNCT06453213What this trial is testingOpen-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset EpilepsyWho this might be right forFocal Onset Seizure SK Life Science, Inc. 49
Testing effectiveness (Phase 2)Study completedNCT05159908What this trial is testingInvestigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Medications in Adults With Focal Onset SeizuresWho this might be right forFocal Onset SeizureFocal Onset Epilepsy Neurocrine Biosciences 101
Not applicableStudy completedNCT04924153What this trial is testingA Natural History Study of Participants With Potassium Sodium-Activated Channel Subfamily T Member 1 (KCNT1)-Related EpilepsyWho this might be right forKCNT1-Related Epilepsy Biogen 35
Not applicableActive Not RecruitingNCT05859854What this trial is testingCenobamate in Adults With Focal-Onset SeizuresWho this might be right forEpilepsyFocal-Onset SeizureNeurological Disorder Aziende Chimiche Riunite Angelini Francesco S.p.A 936
Not applicableEnded earlyNCT04839601What this trial is testingRNS System RESPONSE StudyWho this might be right forEpilepsyPartial SeizureNeurostimulator; Complications+2 more NeuroPace 9
Testing effectiveness (Phase 2)WithdrawnNCT05481905What this trial is testingENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal SeizuresWho this might be right forFocal Epilepsy Engrail Therapeutics INC
Large-scale testing (Phase 3)Study completedNCT00991757What this trial is testingAn Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.Who this might be right forEpilepsyComplex Partial SeizuresEpilepsy, Complex Partial+1 more SK Life Science, Inc. 991
Testing effectiveness (Phase 2)Study completedNCT04244175What this trial is testingA Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset SeizuresWho this might be right forSeizures AbbVie 154
Not applicableUnknownNCT03457961What this trial is testingPost-market Study of AMPA Receptor Antagonists for Epilepsy Patients in Hong KongWho this might be right forFocal EpilepsyGeneralized EpilepsyPartial Seizures, Simple Chinese University of Hong Kong 80
Large-scale testing (Phase 3)WithdrawnNCT00422110What this trial is testingEvaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset SeizuresWho this might be right forEpilepsies, Partial UCB Pharma
Testing effectiveness (Phase 2)Looking for participantsNCT07219407What this trial is testingA Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset SeizuresWho this might be right forFocal EpilepsyEpilepsyRefractory Focal Epilepsy+3 more Rapport Therapeutics Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT04529954What this trial is testingAnti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF InfusionWho this might be right forFocal Epilepsy Cerebral Therapeutics LLC 20